MedTrace Logo

Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?

NCT07312409 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-01-06

No results posted yet for this study

Summary

Millions have developed Long COVID (LC), and recent findings show an association between taurine deficiency (an amino acid) and symptoms in LC. Cost-effective and accessible interventions are needed to improve welfare and reduce healthcare costs. We will investigate the efficacy of 12-week taurine supplementation, on vascular function and the cardio/cerebrovascular responses to upright posture in LC. We will measure resting vascular function with EndoPAT and ultrasound, resting heart rate variability, and the blood pressure, heart rate, and brain blood flow response to 5 minutes of head-up tilt before and after 12-weeks of taurine supplementation in LC.

Conditions

  • Long COVID Syndrome

Interventions

DIETARY_SUPPLEMENT

Taurine supplementation

Participants will take 12-wks taurine supplementation (2 x 675mg twice daily).

Sponsors & Collaborators

  • Long COVID Web

    collaborator UNKNOWN

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • York University

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2026-12-31
Completion
2027-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07312409 on ClinicalTrials.gov